Francisco David Rodriguez (Francisco D Rodríguez, F David Rodriguez, Francisco D Rodriguez)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

International journal of molecular sciences

Cancers

Biomedicines

Current medicinal chemistry

University of Salamanca

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Salamanca Jan 01 1999

Spain

Profesor Titular de Universidad :: Bioquímica y Biología Molecular

Publications

Francisco David Rodriguez, Manuel Lisardo Sánchez, Rafael Coveñas
Neurotensin and Alcohol Use Disorders: Towards a Pharmacological Treatment. International journal of molecular sciences 24 (10) (2023)
Manuel Lisardo Sánchez, Francisco David Rodriguez, Rafael Coveñas
Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies. International journal of molecular sciences 24 (12) (2023)
Francisco David Rodriguez, Rafael Coveñas
Peptidergic Systems as Antitumor Targets: A Right Direction to Fight Cancer? Cancers 15 (20) (2023)
Manuel Lisardo Sánchez, Francisco David Rodriguez, Rafael Coveñas
Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families. Cancers 15 (6) (2023)
Manuel Lisardo Sánchez, Francisco David Rodriguez, Rafael Coveñas
Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies. International journal of molecular sciences 24 (12) (2023)
Rafael Coveñas, Francisco David Rodriguez, Prema Robinson, Miguel Muñoz
The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant. International journal of molecular sciences 24 (21) (2023)
Manuel Lisardo Sánchez, Francisco David Rodriguez, Rafael Coveñas
Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies. International journal of molecular sciences 24 (12) (2023)
Francisco David Rodriguez, Rafael Covenas
Association of Neurokinin-1 Receptor Signaling Pathways with Cancer. Current medicinal chemistry (2023)
Manuel Lisardo Sánchez, Francisco David Rodriguez, Rafael Coveñas
Involvement of the Opioid Peptide Family in Cancer Progression. Biomedicines 11 (7) (2023)
Manuel Lisardo Sánchez, Francisco David Rodriguez, Rafael Coveñas
Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families. Cancers 15 (6) (2023)
Francisco David Rodriguez, Rafael Coveñas
Biochemical Mechanisms Associating Alcohol Use Disorders with Cancers. Cancers 13 (14) (2021)
Xandra Pereiro, Noelia Ruzafa, Arantxa Acera, Alex Fonollosa, Francisco David Rodriguez, Elena Vecino
Dexamethasone protects retinal ganglion cells but not Müller glia against hyperglycemia in vitro. PloS one 13 (11) (2018)

Francisco David Rodriguez.css-eqlu8i{font-size:small;padding-left:4px;} (Francisco D Rodríguez, F David Rodriguez, Francisco D Rodriguez)

Publication Activity (10 Years)

Top Topics

Top Venues

Francisco David Rodriguez (Francisco D Rodríguez, F David Rodriguez, Francisco D Rodriguez)